Your browser doesn't support javascript.
loading
Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer.
Herold, Natalie; Schmolling, Johanna; Ernst, Corinna; Ataseven, Beyhan; Blümcke, Britta; Schömig-Markiefka, Birgid; Heikaus, Sebastian; Göhring, Uwe-Jochen; Engel, Christoph; Lampe, Björn; Rhiem, Kerstin; Harter, Philipp; Hauke, Jan; Schmutzler, Rita K; Hahnen, Eric.
Affiliation
  • Herold N; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Schmolling J; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Ernst C; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Ataseven B; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Blümcke B; Medical School and University Medical Center East Westphalia-Lippe, Klinikum Lippe, Academic Department of Gynecology, Gynecologic Oncology and Obstetrics, Bielefeld University, Detmold, Germany.
  • Schömig-Markiefka B; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Heikaus S; Institute of Pathology, University Hospital Cologne, Cologne, Germany.
  • Göhring UJ; Department of Pathology, Kliniken Essen-Mitte (KEM) Evang. Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
  • Engel C; Department of Gynecology and Obstetrics, Johanniter Krankenhaus, Bonn, Germany.
  • Lampe B; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Rhiem K; Department of Gynecology and Obstetrics, Diakonie Kaiserswerth, Düsseldorf, Germany.
  • Harter P; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Hauke J; Department of Gynecology & Gynecologic Oncology, Kliniken Essen-Mitte (KEM), Essen, Germany.
  • Schmutzler RK; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
  • Hahnen E; Center for Familial Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University of Cologne and University Hospital Cologne, Cologne, Germany.
Cancer Med ; 12(14): 15256-15260, 2023 07.
Article in En | MEDLINE | ID: mdl-37345881
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Risk_factors_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Germ-Line Mutation Type of study: Risk_factors_studies Limits: Female / Humans Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Country of publication: